Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, according to new research. Photo by Adobe Stock/HealthDay News A person ...
Women under age 40 with multiple sclerosis are 8 percent less likely than men to receive disease-modifying drugs, a new study has found. Uncertainty about the impact of these drugs during pregnancy ...
The faster patients can be diagnosed with multiple sclerosis, the sooner they can begin taking the powerful medications that ...
People with multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, and that amount soared to $2,378 annually in 2021, according to a new study. The study examined the ...
Women with multiple sclerosis (MS) are significantly less likely than men to be treated with disease-modifying therapies (DMTs) and highly effective DMTs (HE-DMTs), a new study showed. At comparable ...
A new study found that most therapies used to treat multiple sclerosis (MS) were linked to a higher risk of low birth weight but not miscarriage, premature birth, and major birth defects. The study ...
LYON (Reuters) - Sanofi's Genzyme unit has received positive feedback from U.S. doctors after the recent launch of multiple sclerosis pill Aubagio and is moving toward refiling its FDA application for ...
Everyday Health on MSN
Dealing with brain fog when you have progressive MS
Understand brain fog in progressive MS, its causes, and treatments. Learn self-help strategies to manage daily life, improve ...
In people with active secondary progressive multiple sclerosis (MS), hematopoietic stem cell transplants may delay disability longer than some other MS medications, according to a new study. The study ...
This transcript has been edited for clarity. Anne H. Cross, MD: Hello. I am Dr Anne Cross, and welcome to Medscape's InDiscussion series on multiple sclerosis (MS). Although many MS patients are ...
Even women with more severe MS cases are less likely than men to get critical treatments, a new study finds. Women under age 40 with multiple sclerosis are 8 percent less likely than men to receive ...
A person battling multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, but by 2021 that same patient spent $2,378 annually, a new report finds. Out-of-pocket costs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback